Mitsubishi Tanabe Pharma America, Inc. (MTPA) Stands with the ALS Community [Yahoo! Finance]
MITSUBISHI CH GRP U/ADR (MTLHY)
NASDAQ:AMEX Investor Relations:
mitsubishichem-hd.co.jp/english/ir
Company Research
Source: Yahoo! Finance
We know firsthand the great need for ALS treatments and when there is a setback for one of us, the entire community is affected. We want to reiterate that we remain focused on our mission to support the broader community through research, treatments, advocacy and patient resources. We are dedicated to advancing our understanding of ALS through ongoing research, including continuing to evaluate the full potential of FDA-approved RADICAVA ORS ® (edaravone) and intravenous (IV) RADICAVA ® (edaravone). The U.S. approval of RADICAVA IV was based on Study 19 (MCI186-19), a randomized placebo-controlled Phase 3 study which was conducted prospectively in 137 people who met criteria identified from an exploratory analysis of the Phase 3 MCI186-16 study. In Study 19, on average, patients on RADICAVA ® lost 2.49 fewer points on the ALSFRS-R vs those in the placebo arm (p=0.0013). RADICAVA ORS ® offers the same drug as RADICAVA IV ® in a different formulation. RADICAVA IV and RADICAVA ORS h
Show less
Read more
Impact Snapshot
Event Time:
MTLHY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MTLHY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MTLHY alerts
High impacting MITSUBISHI CH GRP U/ADR news events
Weekly update
A roundup of the hottest topics
MTLHY
News
- Mitsubishi Chemical Group And Two More Top Dividend Stocks [Yahoo! Finance]Yahoo! Finance
- Empty Capsules Market: USD 4.2B by 2029, 6.3% CAGR, Driven by Nutraceuticals & Pharmaceuticals | MarketsandMarkets™ [Yahoo! Finance]Yahoo! Finance
- Mitsubishi Tanabe Pharma America Presents New Results of RADICAVA® (edaravone) for People Living with ALS at the European Network to Cure ALS (ENCALS) Meeting 2024 [Yahoo! Finance]Yahoo! Finance
- Mitsubishi Tanabe Pharma America Presents Final Results from the Global, Phase 3b MT-1186-A02 Post-marketing Study of RADICAVA® (edaravone) in ALS [Yahoo! Finance]Yahoo! Finance
- Mitsubishi Tanabe Pharma America Celebrates Second Anniversary of RADICAVA ORS® (edaravone) Launch in the U.S. [Yahoo! Finance]Yahoo! Finance